{"disease":{"id":"papillary-serous-endometrial-carcinoma","name":"papillary serous endometrial carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04080284","title":"Trial of Maintenance With Niraparib- Uterine Serous Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Northwell Health","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}